![El Mustapha Bahassi, PhD](https://www.uc.edu/news/articles/legacy/healthnews/2013/06/h22807/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1534517798949.jpg)
Noninvasive Biomarker Research Aims to Improve Treatment for Brain Tumors
Glioblastoma multiforme (GBM) remains one of the most challenging forms of malignant brain tumors. This fast-growing central nervous system tumor forms in the supportive tissue of the brain and spinal cord and results in a median patient survival of just 15 months.
With a new T1 pilot grant from UCs Center for Clinical and Translational Science and Training (CCTST), El Mustapha Bahassi, PhD, hopes to give clinicians a new tool in managing the disease more effectively without invasive measures. CCTST is the academic home of the universitys institutional Clinical and Translational Science Award from the National Institutes of Health.
Bahassi is using whole genome sequencing to identify and then track specific tumor mutations (circulating mutant DNA) through the blood.
Whole genome sequencing is a laboratory process to determine the complete DNA sequence of a persons genome (i.e., complete hereditary makeup)at a single time. Genetic instructions from DNA fuel all biologic developments and functions in the body.
"Tumors release small fragments of DNA that carry the same genetic information we would get by doing a tissue biopsy in the brain. Gathering this information from the patient through blood samplesbefore, during and after treatmentcould tell us whether the patient is responding to treatment or likely to have a relapse through blood samples and avoid multiple, invasive brain tumor biopsies, says Bahassi, who is also a research assistant professor in the UC College of Medicine Department of Internal Medicine, Division of Hematology Oncology.
"Utilizing whole genome sequencing could help identify changes in the genomes of brain tumors that drive cancer progression and aid in the development of noninvasive biomarkers to help follow treatment effectiveness and predict tumor recurrence, adds Bahassi.
Basic Scientists and Clinicians Working Together
At the UC Brain Tumor Center, basic scientists and neurosurgeons are working together to tackle the problem in a pre-clinical study using human brain tumor tissue samples. The original study included 10 tumor samples and was funded by UC and small foundation grants from the Mayfield Education & Research Foundation, Shemenski Foundation and LCS/Sahlfeld Foundation
Additional funding from the CTSA has given Bahassi and Warnick resources to collect whole genome sequencing data on an additional 40 patients from the UC Brain Tumor Center to determine if the approach is feasible for a phase-1 clinical trial.
The UC Brain Tumor Center is one of nine centers of the UC Neuroscience Institute and one of five comprehensive disease-based centers of the UC Cancer Institute. Both institutes are partnerships of UC Health and the UC College of Medicine. Learn more about the UC Brain Tumor Center at ucbraintumorcenter.com.
Illustration of tumor DNA in the bloodstream, by Mayfield Clinic
Ronald Warnick, MD, of the UC Brain Tumor Center
Related Stories
UC hosts camp for children, teens who stutter
![Fox 19 logo](/content/dam/refresh/uc-news/news-icons/dark/wxix-dark.png)
July 24, 2024
Children and teens who stutter have learned skills to help them communicate effectively, advocate for themselves and develop confidence about their communication abilities during a weeklong camp at the University of Cincinnati, Fox 19 reported.
Health effects of secondhand marijuana smoke
![Local 12 logo](/content/dam/refresh/uc-news/news-icons/dark/wkrc-logo-dark.png)
July 24, 2024
Local 12 featured the University of Cincinnati's LaTrice Montgomery in a story on the relatively unknown effects of secondhand marijuana smoke.
UC study examines impact of incarceration on youth health
July 19, 2024
Samantha Boch, PhD, at the UC College onf Nursing, has studied the impact of incarceration on child and family health for more than a decade. Her latest research examines youth health in Cincinnati and relies on collaboration with Cincinnati Children's Hospital.